SC 13G/A: Acrivon Therapeutics, Inc.

AI Summary

SC 13G/A filing by Acrivon Therapeutics, Inc..

Risk Assessment

Risk Level: low

FAQ

Key Financial Figures

• $0.001 — OF SECURITIES: Common Stock, par value $0.001 per share (the “Common Stock&rdqu

Filing Documents

• ea0208963-13ga1chione_acri.htm (SC 13G/A) — 85KB
• ea020896301ex24-1_acrivon.htm (EX-24.1) — 8KB
• ea020896301ex24-2_acrivon.htm (EX-24.2) — 8KB
• ea020896301ex24-3_acrivon.htm (EX-24.3) — 7KB
• ea020896301ex24-4_acrivon.htm (EX-24.4) — 8KB
• ea020896301ex99-1_acrivon.htm (EX-99.1) — 4KB
• 0001213900-24-060601.txt ( ) — 120KB

(A) NAME OF ISSUER: Acrivon Therapeutics, Inc

ITEM 1 (A) NAME OF ISSUER: Acrivon Therapeutics, Inc.

(B) ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE

ITEM 1 (B) ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES: 480 Arsenal Way, Suite 100, Watertown, Massachusetts

(A) NAME OF PERSON FILING: This Statement is filed on

ITEM 2 (A) NAME OF PERSON FILING: This Statement is filed on behalf of each of the following persons (collectively, the “Reporting Persons”): (i) Chione Limited. (“Chione”) (ii) Marcin Czernik (iii) Andreas Hadjimichael (iv) Anastasis Nikolaou (v) Wiaczeslaw Smolokowski

(B) ADDRESS OR PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE

ITEM 2 (B) ADDRESS OR PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: The principal business office of each of the Reporting Persons (other than Mr. Smolokowski) is Simou Menardou 5, Kifisia Court. Office 225, 6015 Larnaca, Cyprus. The residence address of Mr. Smolokowski is Chalet Lenotchka, Chemin des Marais 1, Chesieres, Switzerland.

(C) CITIZENSHIP ( i) Chione is a Cyprus corporation

ITEM 2 (C) CITIZENSHIP ( i) Chione is a Cyprus corporation. (ii) Messrs. Hadjimichael and Nikolaou are citizens of the Republic of Cyprus. (iii) Messrs. Czernik and Smolokowski are citizens of the Republic of Poland.

(D) TITLE OF CLASS OF SECURITIES: Common Stock, par value

ITEM 2 (D) TITLE OF CLASS OF SECURITIES: Common Stock, par value $0.001 per share (the “Common Stock”), of Acrivon Therapeutics, Inc., a Delaware corporation (the “Issuer”)

(E) CUSIP NO.: 004890109

ITEM 2 (E) CUSIP NO.: 004890109

IF THIS STATEMENT IS FILED PURSUANT TO §§ 240.13D-1(B)

ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO §§ 240.13D-1(B) OR 240.13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with § 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: 7

OWNERSHIP

ITEM 4. OWNERSHIP The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 and 11 of the cover pages to this Schedule 13G. The percentages set forth herein are calculated based upon 22,194,307 shares of Common Stock outstanding, as of November 3, 2023, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ending September 30, 2023 filed with the Securities and Exchange Commission on November 9, 2023. These shares of Common Stock are owned directly by Chione. Chione’s directors, Marcin Czernik, Andreas Hadjimichael and Anastasis Nikolaou, and its sole stockholder, Wiaczeslaw Smolokowski, may be deemed to share voting and investment power and beneficial ownership of such shares of Common Stock. Each of such directors and stockholder disclaims such voting and investment power and beneficial ownership.

OWNERSHIP OF 5 PERCENT OR LESS OF A CLASS

ITEM 5. OWNERSHIP OF 5 PERCENT OR LESS OF A CLASS. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following .

OWNERSHIP OF MORE THAN 5 PERCENT ON BEHALF OF ANOTHER PERSON

ITEM 6. OWNERSHIP OF MORE THAN 5 PERCENT ON BEHALF OF ANOTHER PERSON. Not applicable.

IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH

ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON. Not applicable.

IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not

ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not applicable.

NOTICE OF DISSOLUTION OF GROUP. Not applicable

ITEM 9. NOTICE OF DISSOLUTION OF GROUP. Not applicable.

CERTIFICATIONS

ITEM 10. CERTIFICATIONS By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. 8 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. July 10, 2024 Date Chione Limited, by /s/ Shalom Leaf, as attorney-in-fact Marcin Czernik, by /s/ Shalom Leaf, as attorney-in-fact Andreas Hadjimichael, by /s/ Shalom Leaf, as attorney-in-fact Anastasis Nikolaou, by /s/ Shalom Leaf, as attorney-in-fact Wiaczeslaw Smolokowski, by /s/ Shalom Leaf, as attorney-in-fact Exhibit Index Exhibit 24.1 – Power of Attorney, dated May 15, 2024, made by Marcin Czernik and Chione Limited in favor of Shalom Leaf Exhibit 24.2 – Power of Attorney, dated May 15, 2024, made by Andreas Hadjimichael and Chione Limited in favor of Shalom Leaf Exhibit 24.3 – Power of Attorney, dated May 15, 2024, made by Wiaczeslaw Smolokowski in favor of Shalom Leaf Exhibit 24.4 – Power of Attorney, dated May 15, 2024, made by Anastasis Nikolaou and Chione Limited in favor of Shalom Leaf Exhibit 99.1 – Joint Filing Agreement, dated July 10, 2024, among the Reporting Persons 9

View Full Filing

View this SC 13G/A filing on SEC EDGAR